Skip to main content
. Author manuscript; available in PMC: 2018 Jul 25.
Published in final edited form as: AAPS J. 2017 Aug 8;19(6):1760–1766. doi: 10.1208/s12248-017-0127-z

Table II.

Diffusion Coefficients for Insulin Drug Products Obtained Using DLS

Drug product Lot no. Normalized diffusion
coefficienta,b (10−6 cm2/s)
% Poly-dispersityc (%Pd) Hydrodynamic
radiusd (nm)
Apidra® 1 0.90 ± 0.04  9.9 ± 0.3 2.7 ± 0.1
2 0.93 ± 0.06   9 ± 4 2.6 ± 0.1
3 0.88 ± 0.05  11 ± 1 2.7 ± 0.1
Humalog® 1 1.02 ± 0.01 10.6 ± 0.3 2.4 ± 0.0
2 0.92 ± 0.09  30 ± 10 2.7 ± 0.2
3 0.93 ± 0.01  14 ± 7 2.6 ± 0.0
Humulin R® 1 1.35 ± 0.01  15 ± 1 1.8 ± 0.0
2 1.34 ± 0.04  11 ± 2 1.8 ± 0.0
3 1.26 ± 0.01  20 ± 1 1.9 ± 0.0
Novolin R® 1 1.31 ± 0.02  11 ± 1 1.9 ± 0.1
2 1.40 ± 0.07 13.2 ± 0.4 1.8 ± 0.1
3 1.32 ± 0.02  16 ± 6 1.8 ± 0.0
Novolog® 1 1.07 ± 0.01  12 ± 0.1 2.3 ± 0.0
2 1.00 ± 0.01  15 ± 5 2.4 ± 0.1
3 1.06 ± 0.03  13 ± 3 2.3 ± 0.1
a

The experimental variation was from two technical repeats

b

The averaged DOSY diffusion coefficient from all 15 lots of insulin was 1.11 × 106 cm2 /s and the RSD was 17%

c

Percent poly-dispersity (%Pd) of the major species is shown. The %Pd value for RNAse A solution was 14.0 ± 0.4%

d

Hydrodynamic radius of the major specie is shown